Cattle: Treatment and metaphylaxis of bovine respiratory disease (BRD)
associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis susceptible to tulathromycin. The presence of the disease in the group must be established before the product is used.
Treatment of infectious bovine keratoconjunctivitis (IBK) associated with
Moraxella bovis susceptible to tulathromycin.
Sheep: Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.